Single-scan Rest/Stress Imaging With Cadmium Zinc Telluride-based SPECT for Coronary Flow Quantification

December 4, 2016 updated by: Tzu-Chen Yen, Chang Gung Memorial Hospital
The investigators aim to address this issue with novel image quantification methods using CZT-based SPECT, which is capable of dynamic data acquisition and therefore feasible for the quantification of the coronary flow. The investigators will use kinetic modeling techniques to design a study that allows the absolute flow quantification. To make this study practical, the investigators will develop a protocol that includes the acquisition of both the rest and stress scan within the same scan that is shorter than 30 minutes. The SPECT-measured flow will be validated against the flow measured with cardiac MRI scans. Patients with high CAD risk will be recruited for the clinical trial. Data from these human subjects will be used for determination of the performance of the developed algorithm. With the proposed rapid scan with absolute quantification capabilities, the investigators expect to increase the diagnosis accuracy while maintaining the patient throughput.

Study Overview

Study Type

Observational

Enrollment (Actual)

30

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Subjects who are suspected with coronary artery diseases and need imaging exams.

Description

Inclusion Criteria:

  1. Subjects with high possibility of coronary artery disease after being evaluated by a cardiologist.
  2. > 20 years old.
  3. Not under infection or other conditions inappropriate for being recruited.
  4. Without myocardial infarction within one week.
  5. With stable blood pressure.
  6. Subjects with normal kidney functions and without allergic reactions to MRI contrast agents.

Exclusion Criteria:

  1. Subjects who cannot take a SPECT scan or do not agree to sign the informed consent.
  2. Pregnant subjects or subjects who are currently breast-feeding.
  3. Those currently under radiation therapies.
  4. Patients with pleural effusion.
  5. Patients who are allergic to SPECT tracers.
  6. Patients with serious psychological disorders.
  7. Patients with asthma.
  8. Patients with stroke within a week.
  9. Patients with AV block.
  10. Patients with sinus syndrome.
  11. Subjects who are currently under other clinical trials.
  12. Subjects with poor kidney functions who are inappropriate for MRI contrast agents.
  13. Subjects with pacemakers.
  14. Subjects with Claustrophobia.
  15. Subjects who cannot hold breath for cardiac MRI studies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Suspected CAD subjects

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Correlation between SPECT- and MRI-measured flow values
Time Frame: through study completion, an average of 3 year
through study completion, an average of 3 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tzu-Chen Yen, MD, PhD, Chang Gung Memorial Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2012

Primary Completion (Actual)

May 1, 2015

Study Completion (Actual)

May 1, 2015

Study Registration Dates

First Submitted

December 1, 2016

First Submitted That Met QC Criteria

December 4, 2016

First Posted (Estimate)

December 7, 2016

Study Record Updates

Last Update Posted (Estimate)

December 7, 2016

Last Update Submitted That Met QC Criteria

December 4, 2016

Last Verified

December 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 101-0453A3

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe